Skip to content

Clinical trials

Phase 3 Depressive Disorder trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Depressive Disorder Phase: Phase 3 Clear all

65 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20014
20024
20043
20055
20069
20073
20083
20092
20105
20116
20122
20131
20141
20171
20181
20191
20202
20211
20232
20241
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed52
Terminated5
Recruiting4
Not yet recruiting2
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi11
Otsuka Pharmaceutical Development & Commercialization, Inc.5
Takeda5
Wyeth is now a wholly owned subsidiary of Pfizer4
Eli Lilly and Company3
GlaxoSmithKline2
Harvard Medical School (HMS and HSDM)2
National Center for Complementary and Integrative Health (NCCIH)2
Shionogi2
University of British Columbia2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Depressive Disorder65
Major Depressive Disorder35
Mood Disorders12
Mental Disorders8
Anxiety Disorders3
Bipolar Disorder3
Dysthymic Disorder2
Recurrence2
Affective Disorders, Psychotic1
Alzheimer Disease1

Trials

Showing 26 to 50 of 65. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.